Paget Leonard Alves
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Analysts Raise AIZN Price Target 13.72% to $19.99. Analysts have raised the consensus price target for Assurant's 2061 subordinated notes by 13.72% to $19.99, suggesting improving sentiment toward the insurer's credit outlook. The notes currently trade near support at $19.09 with an RSI of 28.6, indicating technical oversold conditions. This upward revision in price targets may reflect views that the notes are undervalued at current levels.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KFC Switches Beverage Supplier to Coca-Cola, Impacting Yum! Brands. KFC has ended its partnership with PepsiCo and will now serve Coca‑Cola products. The switch could alter Yum! Brands’ franchise agreements and cost structure, requiring new supply terms. PepsiCo’s loss of KFC may reduce its revenue from the fast‑food chain.
Transaction History
| SYF | ▲ Buy | Grant | 846 | $60K | 9/30/2026 | View on chart |
| SYF | ▲ Buy | Grant | 157 | $13K | 8/17/2026 | View on chart |
| SYF | ▲ Buy | Grant | 789 | $60K | 6/30/2026 | View on chart |
| SYF | ▲ Buy | Grant | 153 | $11K | 5/15/2026 | View on chart |
| SYF | ▲ Buy | Grant | 883 | $60K | 3/31/2026 | View on chart |
| SYF | ▲ Buy | Grant | 147 | $11K | 2/17/2026 | View on chart |
| SYF | ▲ Buy | Grant | 660 | $55K | 12/31/2025 | View on chart |
| SYF | ▲ Buy | Grant | 149 | $11K | 11/17/2025 | View on chart |
| SYF | ▲ Buy | Grant | 775 | $55K | 9/30/2025 | View on chart |
| SYF | ▲ Buy | Grant | 144 | $10K | 8/15/2025 | View on chart |
| SYF | ▲ Buy | Grant | 825 | $55K | 6/30/2025 | View on chart |
| SYF | ▲ Buy | Grant | 165 | $10K | 5/15/2025 | View on chart |
| SYF | ▲ Buy | Grant | 1,039 | $55K | 3/31/2025 | View on chart |
| SYF | ▲ Buy | Grant | 123 | $8K | 2/18/2025 | View on chart |
| SYF | ▲ Buy | Grant | 635 | $41K | 12/31/2024 | View on chart |
| SYF | ▲ Buy | Grant | 121 | $8K | 11/15/2024 | View on chart |
| SYF | ▲ Buy | Grant | 827 | $41K | 9/30/2024 | View on chart |
| SYF | ▲ Buy | Grant | 23 | $1K | 8/15/2024 | View on chart |
| SYF | ▲ Buy | Grant | 875 | $41K | 6/30/2024 | View on chart |
| AIZN | ▲ Buy | Grant | 947 | $0 | 5/24/2024 | View on chart |
| SYF | ▲ Buy | Grant | 26 | $1K | 5/15/2024 | View on chart |
| SYF | ▼ Sell | Other | 64 | $3K | 5/13/2024 | View on chart |
| YUM | ▼ Sell | Open Market | 3,235 | $441K | 5/2/2024 | View on chart |
| YUM | ▼ Sell | Open Market | 3,074 | $419K | 5/2/2024 | View on chart |
| SYF | ▲ Buy | Grant | 957 | $41K | 3/31/2024 | View on chart |
| SYF | ▲ Buy | Grant | 33 | $1K | 2/15/2024 | View on chart |
| SYF | ▼ Sell | Other | 73 | $3K | 2/13/2024 | View on chart |
| SYF | ▲ Buy | Grant | 1,081 | $41K | 12/31/2023 | View on chart |
| SYF | ▲ Buy | Grant | 45 | $1K | 11/9/2023 | View on chart |
| SYF | ▲ Buy | Grant | 1,350 | $41K | 9/30/2023 | View on chart |
| SYF | ▲ Buy | Grant | 39 | $1K | 8/10/2023 | View on chart |
| SYF | ▲ Buy | Grant | 1,217 | $41K | 6/30/2023 | View on chart |
| SYF | ▲ Buy | Grant | 48 | $1K | 5/12/2023 | View on chart |
| AIZN | ▲ Buy | Grant | 1,235 | $0 | 5/12/2023 | View on chart |
| SYF | ▲ Buy | Grant | 1,419 | $41K | 3/31/2023 | View on chart |
| SYF | ▲ Buy | Grant | 35 | $1K | 2/17/2023 | View on chart |
| SYF | ▲ Buy | Grant | 1,256 | $41K | 12/31/2022 | View on chart |
| SYF | ▲ Buy | Grant | 30 | $1K | 11/10/2022 | View on chart |
| SYF | ▲ Buy | Grant | 1,464 | $41K | 9/30/2022 | View on chart |
| SYF | ▲ Buy | Grant | 28 | $1K | 8/11/2022 | View on chart |
| SYF | ▲ Buy | Grant | 1,494 | $41K | 6/30/2022 | View on chart |
| AIZN | ▲ Buy | Grant | 881 | $0 | 5/13/2022 | View on chart |
| SYF | ▲ Buy | Grant | 24 | $793 | 5/12/2022 | View on chart |
| SYF | ▲ Buy | Grant | 1,186 | $41K | 3/31/2022 | View on chart |
| SYF | ▲ Buy | Grant | 17 | $742 | 2/17/2022 | View on chart |
| SYF | ▲ Buy | Grant | 890 | $41K | 12/31/2021 | View on chart |
| SYF | ▲ Buy | Grant | 15 | $753 | 11/12/2021 | View on chart |
| SYF | ▲ Buy | Grant | 844 | $41K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Synchrony Financial Prepares for Q3 Earnings Amid Mixed Analyst Views
Synchrony Financial is approaching its third-quarter earnings report, with analysts expecting lower results compared to previous periods. While some market participants are watching for higher purchase volumes to support performance, recent stock price movements have been volatile. The company's current valuation remains low relative to its peer group, and its preferred shares have seen increased interest due to yield.
Synchrony Financial Prepares for Q3 Earnings Amid Mixed Analyst Views. Synchrony Financial is approaching its third-quarter earnings report, with analysts expecting lower results compared to previous periods. While some market participants are watching for higher purchase volumes to support performance, recent stock price movements have been volatile. The company's current valuation remains low relative to its peer group, and its preferred shares have seen increased interest due to yield.